Related references
Note: Only part of the references are listed.Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients
Archana Anantharaman et al.
BMC CANCER (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Precision medicine for advanced prostate cancer
Stephanie A. Mullane et al.
CURRENT OPINION IN UROLOGY (2016)
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Nicholas D. James et al.
LANCET (2016)
Inferring expressed genes by whole-genome sequencing of plasma DNA
Peter Ulz et al.
NATURE GENETICS (2016)
Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies
Angela Esposito et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2016)
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JAMA ONCOLOGY (2016)
Circulating Tumor Cell Composition in Renal Cell Carcinoma
Ivonne Nel et al.
PLOS ONE (2016)
Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients
Nada Lallous et al.
GENOME BIOLOGY (2016)
High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining
Daniel E. Campton et al.
BMC CANCER (2015)
Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents
M. Crespo et al.
BRITISH JOURNAL OF CANCER (2015)
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
Elizabeth A. Punnoose et al.
BRITISH JOURNAL OF CANCER (2015)
A Targetable GATA2-IGF2 Axis Confers Aggressiveness in Lethal Prostate Cancer
Samuel J. Vidal et al.
CANCER CELL (2015)
Detection and Phenotyping of Circulating Tumor Cells in High-Risk Localized Prostate Cancer
Sumanta K. Pal et al.
CLINICAL GENITOURINARY CANCER (2015)
Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
Xiaoyi Huang et al.
EUROPEAN UROLOGY (2015)
SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer
Evan Y. Yu et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer
Ajjai Alva et al.
JOURNAL OF UROLOGY (2015)
Size and deformability based separation of circulating tumor cells from castrate resistant prostate cancer patients using resettable cell traps
Xi Qin et al.
LAB ON A CHIP (2015)
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Christopher J. Sweeney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
David T. Miyamoto et al.
SCIENCE (2015)
A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer
Runze Jiang et al.
ONCOTARGET (2015)
Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancer
Christophe Legendre et al.
CLINICAL EPIGENETICS (2015)
Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial
Amir Goldkorn et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
Circulating Tumor Cells in Patients with Testicular Germ Cell Tumors
Paulina Nastaly et al.
CLINICAL CANCER RESEARCH (2014)
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Julia A. Beaver et al.
CLINICAL CANCER RESEARCH (2014)
Detection and Characterization of Invasive Circulating Tumor Cells Derived from Men with Metastatic Castration- Resistant Prostate Cancer
Terence W. Friedlander et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Circulating tumor cells detection has independent prognostic Lipact in high-risk non-muscle invasive bladder cancer
Paola Gazzaniga et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer
Amir Goldkorn et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer
Edwin E. Reyes et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
Jens G. Lohr et al.
NATURE BIOTECHNOLOGY (2014)
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
Cassandra L. Hodgkinson et al.
NATURE MEDICINE (2014)
Microfluidic, marker-free isolation of circulating tumor cells from blood samples
Nezihi Murat Karabacak et al.
NATURE PROTOCOLS (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Nanomechanical Biomarkers of Single Circulating Tumor Cells for Detection of Castration Resistant Prostate Cancer
Pawel Osmulski et al.
PROSTATE (2014)
Prognostic role of D-dimer in patients with lung cancer: a meta-analysis
Xuelei Ma et al.
TUMOR BIOLOGY (2014)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis
P. Gazzaniga et al.
ANNALS OF ONCOLOGY (2012)
ApoStream™, a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood
Vishal Gupta et al.
BIOMICROFLUIDICS (2012)
Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study
Michael Rink et al.
EUROPEAN UROLOGY (2012)
The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy
Thomas J. Guzzo et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
Prognostic Significance of Circulating Tumor Cell Count in Patients With Metastatic Hormone-sensitive Prostate Cancer
Luis Resel Folkersma et al.
UROLOGY (2012)
Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer
David T. Miyamoto et al.
CANCER DISCOVERY (2012)
Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer
Medha S. Darshan et al.
CANCER RESEARCH (2011)
Circulating Tumor Cells as a Predictive Biomarker in Patients With Hormone-sensitive Prostate Cancer
Oscar B. Goodman et al.
CLINICAL GENITOURINARY CANCER (2011)
Detection of Circulating Tumor Cells in Metastatic and Clinically Localized Urothelial Carcinoma
Thomas W. Flaig et al.
UROLOGY (2011)
A Cancer Detection Platform Which Measures Telomerase Activity from Live Circulating Tumor Cells Captured on a Microfilter
Tong Xu et al.
CANCER RESEARCH (2010)
Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer
Takatsugu Okegawa et al.
INTERNATIONAL JOURNAL OF UROLOGY (2010)
Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer
Shannon L. Stott et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Detection of circulating tumor cells in patients with urothelial cancer
D. J. Gallagher et al.
ANNALS OF ONCOLOGY (2009)
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
D. Olmos et al.
ANNALS OF ONCOLOGY (2009)
Circulating Tumor Cells in Patients with Castration-Resistant Prostate Cancer Baseline Values and Correlation with Prognostic Factors
Oscar B. Goodman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Renal Cell Carcinoma Correlates with Prognosis
Karen Bluemke et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard et al.
CANCER RESEARCH (2009)
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
Howard I. Scher et al.
LANCET ONCOLOGY (2009)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer
Takatsugu Okegawa et al.
JOURNAL OF UROLOGY (2008)
Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: Initial results in early prostate cancer
John W. Davis et al.
JOURNAL OF UROLOGY (2008)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath et al.
NATURE (2007)
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2007)
Detection of circulating urothelial cancer cells in the blood using the CellSearch system
Michio Naoe et al.
CANCER (2007)
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer
David R. Shaffer et al.
CLINICAL CANCER RESEARCH (2007)
Isolation by size of epithelial tumor cells - A new method for the immunomorphological and molecular characterization of circulating tumor cells
G Vona et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
